Los Angeles Capital Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-25,705	Closed	-$593K	–	1694
2020 Q4	$593K	Buy	25,705 +3,772	+17%	+$87K	﹤0.01%	1137
2020 Q3	$223K	Buy	21,933 +1,350	+7%	+$13.7K	﹤0.01%	1370
2020 Q2	$307K	Buy	20,583 +7,503	+57%	+$112K	﹤0.01%	1285
2020 Q1	$159K	Buy	+13,080	New	+$159K	﹤0.01%	1229